Lung Cancer Tumor Board

NeoGenomics is proud to offer our Molecular Tumor Boards covering relevant topics in cancer care.

Each session, multidisciplinary teams will submit and discuss 2 - 4 patients with expert oncologists. For more information on this and our other tumor boards, please visit (copy and paste into browser).

This series is through March 2021. For invitations to the April 2021 tumor boards and onwards, the registration page will soon be available.

We look forward to having you join us. Please contact the Scientific Collaboration & Engagement team at to inquire about submitting cases for review, or for any questions.